✦ LIBER ✦

The effect of memantine in specific behavioural symptoms in ad outpatients. results of a Greek observational, open-label, 6-month study

✍ Scribed by Kerezoudi, E.; Galanopoulos, A.P.; Saltos, L.; Parashos, I.A.

Book ID: 122820497
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 78 KB
Volume: 333
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2013.07.1288

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effectiveness of memantine in a “beh

The effectiveness of memantine in a “behaviourally disturbed” AD population. Results from a Greek observational, open-label, 6-month study

✍ Galanopoulos, A.P.; Saltos, L.; Kerezoudi, E.; Parashos, I. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

The use of memantine in a Greek outpatie

The use of memantine in a Greek outpatient ad population. The effect of behavioural disturbances and other comorbidity

✍ Saltos, L.; Kerezoudi, E.; Galanopoulos, A.P.; Parashos, I.A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

The effect of topiramate on energy balan

The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension

✍ Angelo Tremblay; Jean-Philippe Chaput; Sonia Bérubé-Parent; Denis Prud’homme; Cl 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 233 KB

A 6-month open-label study of the effect

A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease

✍ C.E. Patterson; A.P. Passmore; V.L.S. Crawford 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

The acute and long-term effectiveness of

The acute and long-term effectiveness of amisulpride in patients with schizophrenia: results of a 12-month open-label prospective follow-up study

✍ Yong Min Ahn; Kyu Young Lee; Chul-Eung Kim; Dae-Yeob Kang; Jeong-Ho Seok; Young 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

## Objective To compare the effectiveness of amisulpride in acute (up to 8 weeks) and maintenance (week 8 to 12 months) phases of a 12‐month course of treatment in a heterogeneous group of patients with schizophrenia. ## Methods We conducted a 12‐month, open‐label clinical trial with flexible dos

77* Phase III Study [CF-302] of inhaled

77* Phase III Study [CF-302] of inhaled dry powder mannitol (Bronchitol(tm)) in cystic fibrosis – results from the 6 month open label phase

✍ M. Aitken; P.A. Flume; D.E. Geller; A. Lapey; J. Zuckerman; K. De Boeck; G. Bell 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB